State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
1-Year Return
24.31%
This Quarter Return
+0.4%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$48.3B
AUM Growth
-$73.8M
(-0.15%)
Cap. Flow
+$248M
Cap. Flow
% of AUM
0.51%
Top 10 Holdings %
Top 10 Hldgs %
19.44%
Holding
2,215
New
156
Increased
1,052
Reduced
474
Closed
103
Top Buys
| 1 |
Pfizer
PFE
|
+$92.1M |
| 2 |
Starbucks
SBUX
|
+$65.4M |
| 3 |
J.M. Smucker
SJM
|
+$62.1M |
| 4 |
ARK Innovation ETF
ARKK
|
+$58.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$58M |
Top Sells
| 1 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$198M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$111M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$103M |
| 4 |
Becton Dickinson
BDX
|
+$78.9M |
| 5 |
American Express
AXP
|
+$74M |
Sector Composition
| 1 | Technology | 23.24% |
| 2 | Financials | 13.95% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Flowserve
FLS
$7.35B
| $569K | ﹤0.01% |
16,401
+873
| +6% | +$30.3K |
|
1652
Virgin Galactic
SPCE
$180M
| $567K | ﹤0.01% |
1,120
+262
| +31% | +$133K |
|
1653
FTI Consulting
FCN
$5.23B
| $566K | ﹤0.01% |
4,202
+196
| +5% | +$26.4K |
|
1654
IDEAYA Biosciences
IDYA
$2.17B
| $563K | ﹤0.01% |
22,100
| – | – |
|
1655
Park Hotels & Resorts
PK
$2.36B
| $563K | ﹤0.01% |
29,422
+1,383
| +5% | +$26.5K |
|
1656
DT Midstream
DTM
$10.9B
| $562K | ﹤0.01% |
+12,153
| New | +$562K |
|
1657
H&R Block
HRB
$6.73B
| $561K | ﹤0.01% |
22,433
+627
| +3% | +$15.7K |
|
1658
Viking Therapeutics
VKTX
$2.91B
| $559K | ﹤0.01% |
89,000
| – | – |
|
1659
Herbalife
HLF
$958M
| $558K | ﹤0.01% |
13,155
+331
| +3% | +$14K |
|
|
UMPQ
1660
DELISTED
Umpqua Holdings Corp
UMPQ
| $558K | ﹤0.01% |
27,572
+1,336
| +5% | +$27K |
|
1661
Karyopharm Therapeutics
KPTI
$53.8M
| $555K | ﹤0.01% |
6,360
| – | – |
|
1662
Aldeyra Therapeutics
ALDX
$333M
| $551K | ﹤0.01% |
62,700
| – | – |
|
1663
Avita Medical
RCEL
$113M
| $546K | ﹤0.01% |
30,800
+596
| +2% | +$10.6K |
|
1664
TD Synnex
SNX
$12.5B
| $543K | ﹤0.01% |
5,217
+247
| +5% | +$25.7K |
|
1665
Ryder
R
$7.61B
| $541K | ﹤0.01% |
6,543
+311
| +5% | +$25.7K |
|
1666
Hawaiian Electric Industries
HE
$2.08B
| $540K | ﹤0.01% |
13,214
+627
| +5% | +$25.6K |
|
|
B
1667
DELISTED
Barnes Group Inc.
B
| $540K | ﹤0.01% |
12,941
-77,773
| -86% | -$3.25M |
|
|
AYX
1668
DELISTED
Alteryx, Inc.
AYX
| $539K | ﹤0.01% |
7,368
+349
| +5% | +$25.5K |
|
1669
Fastly
FSLY
$1.08B
| $536K | ﹤0.01% |
13,253
+626
| +5% | +$25.3K |
|
1670
Taysha Gene Therapies
TSHA
$887M
| $536K | ﹤0.01% |
28,800
| – | – |
|
1671
Akebia Therapeutics
AKBA
$777M
| $535K | ﹤0.01% |
185,734
| – | – |
|
1672
Tower Semiconductor
TSEM
$7.57B
| $535K | ﹤0.01% |
17,726
-3,408
| -16% | -$103K |
|
1673
Air Lease Corp
AL
$7.11B
| $528K | ﹤0.01% |
13,419
+643
| +5% | +$25.3K |
|
1674
Relmada Therapeutics
RLMD
$53.4M
| $527K | ﹤0.01% |
20,100
| – | – |
|
1675
Timken Company
TKR
$5.32B
| $527K | ﹤0.01% |
8,050
+385
| +5% | +$25.2K |
|